{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:07:28Z","timestamp":1790143648330,"version":"4.0.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,30]]},"DOI":"10.7759\/cureus.10141","type":"journal-article","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T01:02:40Z","timestamp":1598835760000},"source":"Crossref","is-referenced-by-count":22,"title":["Moyamoya Disease: A Review of Current Literature"],"prefix":"10.7759","author":[{"given":"Apurv","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anshika","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moises","family":"Romo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystal C","family":"Amoroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FNU","family":"Sonia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2019.7198","article-title":"Epidemiology, diagnosis and treatment of moyamoya disease","volume":"17","author":"Zhang H","year":"2019","unstructured":"Zhang H, Zheng L, Feng L. Epidemiology, diagnosis and treatment of moyamoya disease. Exp Ther Med. 2019, 17:1977-1984. 10.3892\/etm.2019.7198","journal-title":"Exp Ther Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3171\/2009.1.FOCUS08310","article-title":"Moyamoya disease: a summary","volume":"26","author":"Burke GM","year":"2009","unstructured":"Burke GM, Burke AM, Sherma AK, Hurley MC, Batjer HH, Bendok BR. Moyamoya disease: a summary. Neurosurg Focus. 2009, 26:11. 10.3171\/2009.1.FOCUS08310","journal-title":"Neurosurg Focus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(08)70240-0","article-title":"Moyamoya disease: current concepts and future perspectives","volume":"7","author":"Kuroda S","year":"2008","unstructured":"Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008, 7:1056-1066. 10.1016\/s1474-4422(08)70240-0","journal-title":"Lancet Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5853\/jos.2015.01627","article-title":"Moyamoya disease: epidemiology, clinical features, and diagnosis","volume":"18","author":"Kim JS","year":"2016","unstructured":"Kim JS. Moyamoya disease: epidemiology, clinical features, and diagnosis. J Stroke. 2016, 18:2-11. 10.5853\/jos.2015.01627","journal-title":"J Stroke"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3171\/2009.01.FOCUS08309","article-title":"Optimal surgical treatment for moyamoya disease in adults: direct versus indirect bypass","volume":"26","author":"Starke RM","year":"2009","unstructured":"Starke RM, Komotar RJ, Connolly ES. Optimal surgical treatment for moyamoya disease in adults: direct versus indirect bypass. Neurosurg Focus. 2009, 26:E8. 10.3171\/2009.01.FOCUS08309","journal-title":"Neurosurg Focus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3171\/2011.12.peds1172","article-title":"Spontaneous occlusion of the circle of Willis in children: pediatric moyamoya summary with proposed evidence-based practice guidelines","volume":"9","author":"Smith ER","year":"2012","unstructured":"Smith ER, Scott RM. Spontaneous occlusion of the circle of Willis in children: pediatric moyamoya summary with proposed evidence-based practice guidelines. J Neurosurg Pediatr. 2012, 9:353-360. 10.3171\/2011.12.peds1172","journal-title":"J Neurosurg Pediatr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-014-2013-0","article-title":"Nationwide survey on quasi-moyamoya disease in Japan","volume":"156","author":"Hayashi K","year":"2014","unstructured":"Hayashi K, Horie N, Izumo T, Nagata I. Nationwide survey on quasi-moyamoya disease in Japan. Acta Neurochir . 2014, 156:935-940. 10.1007\/s00701-014-2013-0","journal-title":"Acta Neurochir"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00381-005-1230-5","article-title":"Clinical features of familial moyamoya disease","volume":"22","author":"Nanba R","year":"2006","unstructured":"Nanba R, Kuroda S, Tada M, Ishikawa T, Houkin K, Iwasaki Y. Clinical features of familial moyamoya disease. Childs Nerv Syst. 2006, 22:258-262. 10.1007\/s00381-005-1230-5","journal-title":"Childs Nerv Syst"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2006.096040","article-title":"Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprinting","volume":"77","author":"Mineharu Y","year":"2006","unstructured":"Mineharu Y, Takenaka K, Yamakawa H, et al.. Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprinting. J Neurol Neurosurg Psychiatry. 2006, 77:1025-1029. 10.1136\/jnnp.2006.096040","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/jhg.2010.132","article-title":"Narisawa A, et al. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene","volume":"56","author":"Kamada F","year":"2011","unstructured":"Kamada F, Aoki Y. Narisawa A, et al. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet. 2011, 56:34-40. 10.1038\/jhg.2010.132","journal-title":"J Hum Genet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2016.12.119","article-title":"The association of the RNF213 p.R4810K polymorphism with quasi-moyamoya disease and a review of the pertinent literature","volume":"99","author":"Zhang Q","year":"2017","unstructured":"Zhang Q, Liu Y, Yu L, et al.. The association of the RNF213 p.R4810K polymorphism with quasi-moyamoya disease and a review of the pertinent literature. World Neurosurg. 2017, 99:701-708.e1. 10.1016\/j.wneu.2016.12.119","journal-title":"World Neurosurg"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2176%2Fnmc.ra.2019-0059","article-title":"Influence of inflammatory disease on the pathophysiology of moyamoya disease and quasi-moyamoya disease","volume":"59","author":"Mikami T","year":"2019","unstructured":"Mikami T, Suzuki H, Komatsu K, Mikuni N. Influence of inflammatory disease on the pathophysiology of moyamoya disease and quasi-moyamoya disease. Neurol Med Chir. 2019, 59:361-370. 10.2176%2Fnmc.ra.2019-0059","journal-title":"Neurol Med Chir"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2015.07.039","article-title":"Temporal profile of the vascular anatomy evaluated by 9.4-tesla magnetic resonance angiography and histological analysis in mice with the R4859K mutation of RNF213, the susceptibility gene for moyamoya disease","volume":"1624","author":"Kanoke A","year":"2015","unstructured":"Kanoke A, Fujimura M, Niizuma K, et al.. Temporal profile of the vascular anatomy evaluated by 9.4-tesla magnetic resonance angiography and histological analysis in mice with the R4859K mutation of RNF213, the susceptibility gene for moyamoya disease. Brain Res. 2015, 1624:497-505. 10.1016\/j.brainres.2015.07.039","journal-title":"Brain Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/wnr.0000000000000289","article-title":"Increased vascular MMP-9 in mice lacking RNF213: moyamoya disease susceptibility gene","volume":"25","author":"Sonobe S","year":"2014","unstructured":"Sonobe S, Fujimura M, Niizuma K, et al.. Increased vascular MMP-9 in mice lacking RNF213: moyamoya disease susceptibility gene. Neuroreport. 2014, 25:1442-1446. 10.1097\/wnr.0000000000000289","journal-title":"Neuroreport"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.0000148237.13659.e6","article-title":"Increased expression of hepatocyte growth factor in cerebrospinal fluid and intracranial artery in moyamoya disease","volume":"35","author":"Nanba R","year":"2004","unstructured":"Nanba R, Kuroda S, Ishikawa T, Houkin K, Iwasaki Y. Increased expression of hepatocyte growth factor in cerebrospinal fluid and intracranial artery in moyamoya disease. Stroke. 2004, 35:2837-2842. 10.1161\/01.str.0000148237.13659.e6","journal-title":"Stroke"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1159\/000121249","article-title":"Elevation of cerebrospinal fluid levels of basic fibroblast growth factor in moyamoya and central nervous system disorders","volume":"27","author":"Malek AM","year":"1997","unstructured":"Malek AM, Connors S, Robertson RL, Folkman J, Scott RM. Elevation of cerebrospinal fluid levels of basic fibroblast growth factor in moyamoya and central nervous system disorders. Pediatr Neurosurg. 1997, 27:182-189. 10.1159\/000121249","journal-title":"Pediatr Neurosurg"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1998.89.4.0623","article-title":"Role of transforming growth factor-beta1 in the pathogenesis of moyamoya disease","volume":"89","author":"Hojo M","year":"1998","unstructured":"Hojo M, Hoshimaru M, Miyamoto S, et al.. Role of transforming growth factor-beta1 in the pathogenesis of moyamoya disease. J Neurosurg. 1998, 89:623-629. 10.3171\/jns.1998.89.4.0623","journal-title":"J Neurosurg"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.108.529420","article-title":"Increased levels of circulating endothelial progenitor cells in patients with Moyamoya disease","volume":"40","author":"Rafat N","year":"2009","unstructured":"Rafat N, Beck GCh, Pe\u00f1a-Tapia PG, Schmiedek P, Vajkoczy P. Increased levels of circulating endothelial progenitor cells in patients with Moyamoya disease. Stroke. 2009, 40:432-438. 10.1161\/strokeaha.108.529420","journal-title":"Stroke"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.29.7.1347","article-title":"Clinical features of moyamoya disease in the United States","volume":"29","author":"Chiu D","year":"1998","unstructured":"Chiu D, Shedden P, Bratina P, Grotta JC. Clinical features of moyamoya disease in the United States. Stroke. 1998, 29:1347-1351. 10.1161\/01.str.29.7.1347","journal-title":"Stroke"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3171\/2014.10.jns132369","article-title":"Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China","volume":"122","author":"Liu XJ","year":"2015","unstructured":"Liu XJ, Zhang D, Wang S, et al.. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China. J Neurosurg. 2015, 122:237-481. 10.3171\/2014.10.jns132369","journal-title":"J Neurosurg"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2009.181487","article-title":"The different infarct patterns between adulthood-onset and childhood-onset moyamoya disease","volume":"82","author":"Cho HJ","year":"2011","unstructured":"Cho HJ, Jung YH, Kim YD, Nam HS, Kim DS, Heo JH. The different infarct patterns between adulthood-onset and childhood-onset moyamoya disease. J Neurol Neurosurg Psychiatry. 2011, 82:38-40. 10.1136\/jnnp.2009.181487","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2008.145078","article-title":"Changing ischaemic lesion patterns in adult moyamoya disease","volume":"80","author":"Kim JM","year":"2009","unstructured":"Kim JM, Lee SH, Roh JK. Changing ischaemic lesion patterns in adult moyamoya disease. J Neurol Neurosurg Psychiatry. 2009, 80:36-40. 10.1136\/jnnp.2008.145078","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0b013e318249f71f","article-title":"Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease","volume":"78","author":"Miyatake S","year":"2012","unstructured":"Miyatake S, Miyake N, Touho H, et al.. Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology. 2012, 78:803-810. 10.1212\/wnl.0b013e318249f71f","journal-title":"Neurology"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/jhg.2012.105","article-title":"Sibling cases of moyamoya disease having homozygous and heterozygous c.14576G>A variant in RNF213 showed varying clinical course and severity","volume":"57","author":"Miyatake S","year":"2012","unstructured":"Miyatake S, Touho H, Miyake N, et al.. Sibling cases of moyamoya disease having homozygous and heterozygous c.14576G>A variant in RNF213 showed varying clinical course and severity. J Hum Genet. 2012, 57:804-806. 10.1038\/jhg.2012.105","journal-title":"J Hum Genet"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s00381-004-0962-y","article-title":"Arterio-embolic ischemic stroke in children with moyamoya disease","volume":"21","author":"Horn P","year":"2005","unstructured":"Horn P, Bueltmann E, Buch CV, Schmiedek P. Arterio-embolic ischemic stroke in children with moyamoya disease. Childs Nerv Syst. 2005, 21:104-107. 10.1007\/s00381-004-0962-y","journal-title":"Childs Nerv Syst"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.1983.tb13848.x","article-title":"Childhood moyamoya presenting as dementia: report of a case","volume":"25","author":"Levin SD","year":"1983","unstructured":"Levin SD, Hoare RD, Robinson RO. Childhood moyamoya presenting as dementia: report of a case. Dev Med Child Neurol. 1983, 25:794-797. 10.1111\/j.1469-8749.1983.tb13848.x","journal-title":"Dev Med Child Neurol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1159\/000350203","article-title":"Asymptomatic cerebral microbleeds in adult patients with moyamoya disease: a prospective cohort study with 2 years of follow-up","volume":"35","author":"Sun W","year":"2013","unstructured":"Sun W, Yuan C, Liu W, et al.. Asymptomatic cerebral microbleeds in adult patients with moyamoya disease: a prospective cohort study with 2 years of follow-up. Cerebrovasc Dis. 2013, 35:469-475. 10.1159\/000350203","journal-title":"Cerebrovasc Dis"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3171\/ped.2005.103.5.0439","article-title":"Headache in pediatric moyamoya disease: review of 204 consecutive cases","volume":"103","author":"Seol HJ","year":"2005","unstructured":"Seol HJ, Wang KC, Kim SK, Hwang YS, Kim KJ, Cho BK. Headache in pediatric moyamoya disease: review of 204 consecutive cases. J Neurosurg. 2005, 103:439-442. 10.3171\/ped.2005.103.5.0439","journal-title":"J Neurosurg"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.18926\/amo\/54497","article-title":"Moyamoya disease: a review of clinical research","volume":"70","author":"Hishikawa T","year":"2016","unstructured":"Hishikawa T, Sugiu K, Date I. Moyamoya disease: a review of clinical research. Acta Med Okayama. 2016, 70:229-236. 10.18926\/amo\/54497","journal-title":"Acta Med Okayama"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/S0303-8467(97)00082-6","article-title":"Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan","volume":"99","author":"Fukui M","year":"1997","unstructured":"Fukui M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg. 1997, 99:S238-S240. 10.1016\/S0303-8467(97)00082-6","journal-title":"Clin Neurol Neurosurg"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.2176\/nmc.52.245","article-title":"Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis; Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis)","volume":"52","year":"2012","unstructured":"Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis; Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir (Tokyo). 2012, 52.245-266. 10.2176\/nmc.52.245","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.2176\/nmc.ra.2014-0307","article-title":"Diagnosis of moyamoya disease: international standard and regional differences","volume":"55","author":"Fujimura M","year":"2015","unstructured":"Fujimura M, Tominaga T. Diagnosis of moyamoya disease: international standard and regional differences. Neurol Med Chir. 2015, 55:189-193. 10.2176\/nmc.ra.2014-0307","journal-title":"Neurol Med Chir"},{"key":"ref33","article-title":"\"Ivy sign\" on fluid-attenuated inversion-recovery images in childhood moyamoya disease","volume":"20","author":"Maeda M","year":"1999","unstructured":"Maeda M, Tsuchida C. \"Ivy sign\" on fluid-attenuated inversion-recovery images in childhood moyamoya disease. Am J Neuroradiol. 1999, 20:1836-1838.","journal-title":"Am J Neuroradiol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.a2568","article-title":"\"Brush Sign\" on susceptibility-weighted MR imaging indicates the severity of moyamoya disease","volume":"32","author":"Horie N","year":"2011","unstructured":"Horie N, Morikawa M, Nozaki A, Hayashi K, Suyama K, Nagata I. \"Brush Sign\" on susceptibility-weighted MR imaging indicates the severity of moyamoya disease. Am J Neuroradiol. 2011, 32:1697-1702. 10.3174\/ajnr.a2568","journal-title":"Am J Neuroradiol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1979.00500370046008","article-title":"Electroencephalographic findings in children with moyamoya disease","volume":"36","author":"Kodama N","year":"1979","unstructured":"Kodama N, Aoki Y, Hiraga H, Wada T, Suzuki J. Electroencephalographic findings in children with moyamoya disease. Arch Neurol. 1979, 36:16-19. 10.1001\/archneur.1979.00500370046008","journal-title":"Arch Neurol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1378%2Fchest.11-2308","article-title":"Antithrombotic therapy in neonates and children","volume":"141","author":"Monagle P","year":"2012","unstructured":"Monagle P, Chan AKC, Goldenberg NA, Ichord RN, Journeycake JM, Nowak-G\u00f6ttl U, Vesely SK. Antithrombotic therapy in neonates and children. Chest. 2012, 141:E737S-E801S. 10.1378%2Fchest.11-2308","journal-title":"Chest"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1080\/01616412.2019.1580455","article-title":"Cilostazol may improve cognition better than clopidogrel in non-surgical adult patients with ischemic moyamoya disease: subanalysis of a prospective cohort","volume":"41","author":"Ando S","year":"2019","unstructured":"Ando S, Tsutsui S, Miyoshi K, et al.. Cilostazol may improve cognition better than clopidogrel in non-surgical adult patients with ischemic moyamoya disease: subanalysis of a prospective cohort. Neurol Res. 2019, 41:480-487. 10.1080\/01616412.2019.1580455","journal-title":"Neurol Res"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-019-01165-9","article-title":"Cerebrovascular events after surgery versus conservative therapy for moyamoya disease: a meta-analysis","volume":"119","author":"Wouters A","year":"2019","unstructured":"Wouters A, Smets I, Van den Noortgate W, Steinberg GK, Lemmens R. Cerebrovascular events after surgery versus conservative therapy for moyamoya disease: a meta-analysis. Acta Neurol Belg. 2019, 119:305-313. 10.1007\/s13760-019-01165-9","journal-title":"Acta Neurol Belg"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1227\/01.neu.0000114140.41509.14","article-title":"Moyamoya disease among young patients: its aggressive clinical course and the role of active surgical treatment","volume":"54","author":"Kim SK","year":"2004","unstructured":"Kim SK, Seol HJ, Cho BK, Hwang YS, Lee DS, Wang KC. Moyamoya disease among young patients: its aggressive clinical course and the role of active surgical treatment. Neurosurgery. 2004, 54:840-846. 10.1227\/01.neu.0000114140.41509.14","journal-title":"Neurosurgery"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2019.04.062","article-title":"Meta-analysis of prognosis of different treatments for symptomatic moyamoya disease","volume":"127","author":"Li Q","year":"2019","unstructured":"Li Q, Gao Y, Xin W, et al.. Meta-analysis of prognosis of different treatments for symptomatic moyamoya disease. World Neurosurg. 2019, 127:354-361. 10.1016\/j.wneu.2019.04.062","journal-title":"World Neurosurg"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.113.004386","article-title":"Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial","volume":"45","author":"Miyamoto S","year":"2014","unstructured":"Miyamoto S, Yoshimoto T, Hashimoto N, et al.. Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial. Stroke. 2014, 45:1415-1421. 10.1161\/strokeaha.113.004386","journal-title":"Stroke"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3171\/2011.11.jns11944","article-title":"The efficacy of superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease complaining of severe headache","volume":"116","author":"Okada Y","year":"2012","unstructured":"Okada Y, Kawamata T, Kawashima A, Yamaguchi K, Ono Y, Hori T. The efficacy of superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease complaining of severe headache. J Neurosurg. 2012, 116:672-679. 10.3171\/2011.11.jns11944","journal-title":"J Neurosurg"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.15390","article-title":"Progress on complications of direct bypass for moyamoya disease","volume":"13","author":"Yu J","year":"2016","unstructured":"Yu J, Shi L, Guo Y, Xu B, Xu K. Progress on complications of direct bypass for moyamoya disease. Int J Med Sci. 2016, 13:578-587. 10.7150\/ijms.15390","journal-title":"Int J Med Sci"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1227\/neu.0000000000000238","article-title":"Minocycline prevents focal neurological deterioration due to cerebral hyperperfusion after extracranial-intracranial bypass for moyamoya disease","volume":"74","author":"Fujimura M","year":"2014","unstructured":"Fujimura M, Niizuma K, Inoue T, Sato K, Endo H, Shimizu H, Tominaga T. Minocycline prevents focal neurological deterioration due to cerebral hyperperfusion after extracranial-intracranial bypass for moyamoya disease. Neurosurgery. 2014, 74:163-170. 10.1227\/neu.0000000000000238","journal-title":"Neurosurgery"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.117.018563","article-title":"Surgical management of moyamoya disease","volume":"49","author":"Acker G","year":"2018","unstructured":"Acker G, Fekonja L, Vajkoczy P. Surgical management of moyamoya disease. Stroke. 2018, 49:476-482. 10.1161\/strokeaha.117.018563","journal-title":"Stroke"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3892%2Fetm.2018.5850","article-title":"Clinical and angiographic outcomes after combined direct and indirect bypass in adult patients with moyamoya disease: a retrospective study of 76 procedures","volume":"15","author":"Zhao J","year":"2018","unstructured":"Zhao J, Liu H, Zou Y, Zhang W, He S. Clinical and angiographic outcomes after combined direct and indirect bypass in adult patients with moyamoya disease: a retrospective study of 76 procedures. Exp Ther Med. 2018, 15:3570-3576. 10.3892%2Fetm.2018.5850","journal-title":"Exp Ther Med"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000007819","article-title":"Predictors of clinical or cerebral lesion progression in adult moyamoya angiopathy","volume":"93","author":"Herv\u00e9 D","year":"2019","unstructured":"Herv\u00e9 D, Ibos-Aug\u00e9 N, Calvi\u00e8re L, et al.. Predictors of clinical or cerebral lesion progression in adult moyamoya angiopathy. Neurology. 2019, 93:388-397. 10.1212\/wnl.0000000000007819","journal-title":"Neurology"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.5137\/1019-5149.jtn.22598-18.3","article-title":"Effect of surgery on the long-term functional outcome of moyamoya disease: a meta-analysis","volume":"29","author":"Yao Z","year":"2019","unstructured":"Yao Z, You C  . Effect of surgery on the long-term functional outcome of moyamoya disease: a meta-analysis. Turk Neurosurg. 2019, 29:171-179.  10.5137\/1019-5149.jtn.22598-18.3","journal-title":"Turk Neurosurg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/40232-moyamoya-disease-a-review-of-current-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:21:51Z","timestamp":1707506511000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/40232-moyamoya-disease-a-review-of-current-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,30]]},"references-count":48,"URL":"https:\/\/doi.org\/10.7759\/cureus.10141","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,30]]}}}